Keywords: NASH، استاتو هپاتیت غیر الکلی; CC, Cryptogenic cirrhosis; CEP, Chromosome enumeration probes; FISH, Fluorescence in situ hybridization; HCC, Hepatocellular carcinoma; NAFLD, Non-alcoholic fatty liver disease; NASH, Non-alcoholic steatohepatitis; PBS, Phosphate buffered saline; TA, Telo
مقالات ISI NASH، استاتو هپاتیت غیر الکلی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; IHL, intrahepatic lymphocytes; NASH, non-alcoholic steatohepatitis; PPAR, peroxisome proliferator-activated receptor; ER, endoplasmic reticulumInterleukin-15; NAFLD; Mice; Liver; Inflammation
Keywords: NASH، استاتو هپاتیت غیر الکلی; Non-alcoholic fatty liver disease; Serum fatty acid composition; Liver fatty acid composition; Fatty acid desaturase; Hepatic mRNA expressionNAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; FA, fatty acid; VLCD, very low calo
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; CV, cardiovascular; CVD, cardiovascular disease; MetS, metabolic syndrome; AT, adipose tissue; TG, triglycerides; DM, diabetes mellitus; NASH, non-alcoholic steatohepatitis; CVRF, cardiovascular risk factor; cIMT,
Keywords: NASH، استاتو هپاتیت غیر الکلی; ASH, alcoholic steatohepatitis; NASH, non-alcoholic steatohepatitis; NAFLD, non-alcoholic fatty liver disease; ALD, alcoholic liver disease; DAMPs, damage-associated molecular patterns; PAMPs, pathogen-associated molecular patterns; LPS, lipopolysaccharid
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; TG, triglycerides; NASH, non-alcoholic steatohepatitis; HSCs, hepatic stellate cells; alpha-SMA, smooth muscle alpha-actin; IL-8, interleukin-8; TNF-alpha, tumor necrosis alpha; TGF-beta1, transforming growth fact
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; HFC, high fat, high cholesterol and cholate; RSV, resveratrol; AMPK, AMP-activated protein kinase; SIRT1, silent information regulation-2 homolog-1; HFD, high-fat diet; TG, tri
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; FGF21, fibroblast growth factor 21; SREBP-1c, sterol regulatory element-binding protein-1c; ACC, acetyl-CoA carboxylase; FAS, fatty acid synthase; SCD1, stearoyl-CoA desaturase
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; T2DM, type 2 diabetes mellitus; NASH, non-alcoholic steatohepatitis; ER, endoplasmic reticulum; ERAD, ER-associated degradation; UPR, unfolded protein response; PERK, protein kinase RNA-activated (PKR)-like ER kin
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; PNPLA3, patatin-like phospholipase domain-containing protein3; ALT, alanine aminotransferase; HOMA-IR, homeostasis model of insulin resistance; MetS, metabolic syndrome; US, ul
Keywords: NASH، استاتو هپاتیت غیر الکلی; IR, insulin resistance; MetS, metabolic syndrom; NAFLD, non-alcoholic fatty liver disease; NAS, NAFLDactivity score; NASH, non-alcoholic steatohepatitis; PNPLA3, patatin-like phospholipase domain-containing 3 gene; T2DM, type 2 diabetes mellitus; TM6SF2,
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; DPP-4, dipeptidyl peptidase 4; GLP-1, glucagon-like peptide-1; GIP, glucose-dependent insulinotropic polypeptide; HbA1c, hemoglobin A1c; SREBP-1c, sterol regulatory element bin
Ligustrazine disrupts lipopolysaccharide-activated NLRP3 inflammasome pathway associated with inhibition of Toll-like receptor 4 in hepatocytes
Keywords: NASH، استاتو هپاتیت غیر الکلی; DMEM, Dulbecco’s modified eagle medium; DMSO, dimethylsulfoxide; ELISA, enzyme-linked immunosorbent assay; FBS, fetal bovine serum; IL-1β, interleukin-1β; LPS, lipopolysaccharide; NASH, non-alcoholic steatohepatitis; NLR, NOD-like receptor; NLRP3, NACHT,
Fructose consumption induces hypomethylation of hepatic mitochondrial DNA in rats
Keywords: NASH، استاتو هپاتیت غیر الکلی; MetS, metabolic syndrome; mtDNA, mitochondrial DNA; NAFLD, non-alcoholic fatty liver disease; mt-ND6, mitochondrial NADH dehydrogenase 6; NASH, non-alcoholic steatohepatitis; HDLC, high-density lipoprotein cholesterol; TET, ten-eleven translocationMetabol
Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model
Keywords: NASH، استاتو هپاتیت غیر الکلی; Autoimmune hepatitis; NAFLD; CYP2D6; Mouse model; Hepatic fibrosisNAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; HCC, hepatocellular carcinoma; AIH, autoimmune hepatitis; CYP2D6, cytochrome P450 2D6; LKM-1, type 1 liver/kid
The glucagon-like peptide-1 analogue exendin-4 reverses impaired intracellular Ca2 + signalling in steatotic hepatocytes
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; T2D, type 2 diabetes; [Ca2 +]cyt, cytoplasmic free Ca2 + concentration; PKC, protein kinase C; PKA, protein kinase A; ER, endoplasmic reticulum; SERCA, sarco/endoplasmic reticu
Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: Results from the WELCOME trial
Keywords: NASH، استاتو هپاتیت غیر الکلی; CI, confidence interval; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; HA, hyaluronic acid; MRI, magnetic resonance imaging; MRS, magnetic resonance spectroscopy; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; PIIN
Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration
Keywords: NASH، استاتو هپاتیت غیر الکلی; metreleptin, recombinant human leptin; NAFLD, non-alcoholic fatty liver disease; fetuin-A, α2-Heremans-Schmid Glycoprotein, AHSG; NASH, Non-alcoholic steatohepatitis; BIDMC, Beth Israel Deaconess Medical Center; HA, hypothalamic amenorrhea; ATCC, American
Role of immunodeficient animal models in the development of fructose induced NAFLD
Keywords: NASH، استاتو هپاتیت غیر الکلی; NASH, non-alcoholic steatohepatitis; CHO, cholesterol; TGY, tryglycerides; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PBMC, peripheral blood mononuclear cell; SREBP-1c, sterol regulatory element-binding protein; MCP-1, monocyte attrac
Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report
Keywords: NASH، استاتو هپاتیت غیر الکلی; liver transplantation; non-alcoholic fatty liver disease; portal hypertension; NAFLD; NASHNAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; LT, liver transplantation; EFAD, essential fatty acid deficiency; BMI, body mass index
Prevalence and associated metabolic factors of fatty liver disease in the elderly
Keywords: NASH، استاتو هپاتیت غیر الکلی; FLD, fatty liver disease; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; MS, metabolic syndrome; TC, total cholesterol; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SUA, serum uric acid; AL
Association between the Pro12Ala polymorphism of PPAR-γ gene and the non-alcoholic fatty liver disease: A meta-analysis
Keywords: NASH، استاتو هپاتیت غیر الکلی; PPAR-γ, peroxisome proliferator activated receptor-γ; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; MS, metabolic syndrome; SNP, single nucleotide polymorphism; CI, confidence interval; OR, odds ratio; HWE, Hardy–Weinberg
Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NHANES, National Health and Nutrition Examination Survey; HDL-C, high density lipoprotein cholesterol; eGFR, estimated glomerular filtration rate; HOMA-IR, homeostasis model as
High prevalence of normal serum albumin in NASH patients with ascites: A retrospective analysis
Keywords: NASH، استاتو هپاتیت غیر الکلی; HVPG, Hepatic venous pressure gradient; SAAG, Serum ascites albumin gradient; CTP, Child Turcotte Pugh; MELD, Model for End-Stage Liver Disease; NASH, Non-alcoholic steatohepatitis; HCV, Hepatitis C virus; TIPS, Transjugular Intrahepatic Porto-systemic Sh
Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; FFA, free fatty acid; ER, endoplasmic reticulum; JNK, Jun N-terminal kinase; NASH, non-alcoholic steatohepatitis; NAS, NASH activity score; MCD, methionine and choline deficient; HFD, high fat diet; SFA, saturated
Non-alcoholic steatohepatitis in morbidly obese patients
Keywords: NASH، استاتو هپاتیت غیر الکلی; NASH, Non-alcoholic steatohepatitis; NAFLD, Non-alcoholic fatty liver disease; LPS, Lipopolysaccharide; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; TNF, Tumor necrosis factor; IL, Interleukin
Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, Non-alcoholic fatty liver disease; 1H-MRS, Proton Magnetic Resonance Spectroscopy; MCD diet, Methionine/choline-deficient diet; H&E, Hematoxylin and eosin staining; NASH, Non-alcoholic steatohepatitis; PRESS, Point resolved spectroscopic sequence;
Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes
Keywords: NASH، استاتو هپاتیت غیر الکلی; ABCG5, ATP binding cassette transporters G5; DPP-4, dipeptidyl peptidase-4; FFA, free fatty acids; GLP-1, glucagon-like peptide-1; NASH, non-alcoholic steatohepatitis; NPC1L1, Niemann-Pick C1-like 1; TC, total cholesterol; TG, triglycerideEzetimibe; Gluca
Rescuing hepatocytes from iron-catalyzed oxidative stress using vitamins B1 and B6
Keywords: NASH، استاتو هپاتیت غیر الکلی; ROS, reactive oxygen species; LPO, lipid peroxidation; MMP, mitochondrial membrane potential; Fe, iron; NASH, non-alcoholic steatohepatitis; DCFD, 2′,7′-dichlorofluorescin diacetate; PIH, pyridoxal isonicotinoyl hydrazone; BHA, butylated hydroxyanisole; D
Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice
Keywords: NASH، استاتو هپاتیت غیر الکلی; NASH, non-alcoholic steatohepatitis; LXR, liver X receptor; APOE2ki, humanized apolipoprotein E2 knock-in; NAFLD, non-alcoholic fatty liver disease; LDL, low density lipoprotein; HFC, high fat, high cholesterol; FF, fenofibrate; PPARα, peroxisome prolifer
Long-term effect of liver transplantation on cirrhotic autonomic cardiac dysfunction
Keywords: NASH، استاتو هپاتیت غیر الکلی; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HF, high frequency; HRV, heart rate variability; LF, low frequency; LT, liver transplantation; MELD, model for end-stage liver disease; NASH, non-alcoholic steatohepatitis; RMS
Clerodendron glandulosum.Coleb extract ameliorates high fat diet/fatty acid induced lipotoxicity in experimental models of non-alcoholic steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکلی; NASH, non-alcoholic steatohepatitis; IR, insulin resistance; CG, Clerodendron glandulousm.Coleb extract; HepG2, Human hepatoblastoma cell line; TG, triglycerides; FFA, free fatty acids; AST, aspartate aminotransferase; ALT, alanine aminotransferase; DCF-D
Fatty liver and lipotoxicity
Keywords: NASH، استاتو هپاتیت غیر الکلی; CAR (NR1I3), constitutive androstane receptor; CYP2E1, cytochrome P450 2E1; ER, endoplasmic reticulum; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; IR, insulin resistance; FA, fatty acids; PPAR, peroxisome proliferator-ac
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
Keywords: NASH، استاتو هپاتیت غیر الکلی; α-SMA, α-smooth muscle actin; AngII, angiotensin II; BDL, bile duct ligation; GFP, green fluorescent protein; HSC, hepatic stellate cell; JNK, c-Jun N-terminal kinase; NASH, non-alcoholic steatohepatitis; PDGF, platelet-derived growth factor; p-JNK, phosp
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6−174G/C polymorphism is associated with non-alcoholic steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; IL-6, interleukin-6; PC-1, plasma cell-1; MTP, microsomal transfer protein; HOMA-IR, homeostasis model assessment-insulinresistance; PCR, polymerase chain reaction; RFLP, restr
Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases
Keywords: NASH، استاتو هپاتیت غیر الکلی; Oxaliplatin; 5-Fluorouracil; Sinusoidal dilatation; Chemotherapy; Perioperative morbidity; Colorectal cancer liver metastasesNAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NAS, NAFLD activity score; SOS, sinusoidal obstruct
Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; SS, simple steatosis; MF, minimal findings; HOMA, homeostasis model assessment; PUFA, polyunsaturated fatty acids; LPO, lipid peroxides; AOP, antioxidant potentialPolyunsaturat
Mitochondrial involvement in non-alcoholic steatohepatitis
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; ROS, reactive oxygen species; FFAs, free fatty acids; CPT1, carnitine palmitoyl transferase-1; PPARs, peroxisome proliferators-activated receptors; ΔΨ, mitochondrial membrane p
Effects of steatosis on drug-metabolizing capability of primary human hepatocytes
Keywords: NASH، استاتو هپاتیت غیر الکلی; C6OH, chlorozoxazone 6-hydroxylation; D4OH, diclofenac 4′-hydroxylation; ECOD, 7-ethoxycoumarin O-deethylation; FFA, free fatty acids; MROD, 7-methoxyresorufin O-demethylation; NASH, non-alcoholic steatohepatitis; OHT, hydroxytestosterone; P450, cytochrom
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
Keywords: NASH، استاتو هپاتیت غیر الکلی; Fatty liver; Non-alcoholic steatohepatitis; Atherosclerosis; Cardiovascular riskMS, metabolic syndrome; T2DM, type 2 diabetes mellitus; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; IR, insulin resistance; GH, growth hormo
Hepatic histology in obese patients undergoing bariatric surgery
Keywords: NASH، استاتو هپاتیت غیر الکلی; NAFLD, non-alcoholic fatty liver disesase; NASH, non-alcoholic steatohepatitis; IR, insulin resistance; BMI, body mass index; DM, diabetes mellitus; WHR, waist to hip ratio; AST, alanine aminotransferase; ALT, aspartate aminotransferaseNon-alcoholic fatty
Metabolic profiling of livers and blood from obese Zucker rats
Keywords: NASH، استاتو هپاتیت غیر الکلی; Nuclear magnetic resonance spectroscopy (NMR); Metabolomics; Methionine; Energy balance; Triglycerides; ObesityFFA, free fatty acids; NAFLD, nonalcoholic fatty liver disease; NASH, non-alcoholic steatohepatitis; NMR, nuclear magnetic resonance spectroscop
Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes
Keywords: NASH، استاتو هپاتیت غیر الکلی; ALD, alcoholic liver disease; CPR, NADPH CYP reductase; CYP2E1, cytochrome P450 2E1; GSH, reduced glutathione; NASH, non-alcoholic steatohepatitis; ROS, reactive oxygen species; PKA, protein kinase A; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazol